 | • レポートコード：GIR-2104Z00295 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、先端巨大症のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。先端巨大症の種類別市場規模（ソマトスタチン類似体、ドーパミン作動薬、成長ホルモン受容体拮抗薬、その他）、用途別市場規模（病院、診療所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・先端巨大症の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Valeo、Continental、Magna International、Hitachi Automotive、Fujitsu、Ficosa ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ソマトスタチン類似体、ドーパミン作動薬、成長ホルモン受容体拮抗薬、その他 ・用途別分析2016年-2026年：病院、診療所 ・先端巨大症の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・先端巨大症のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・先端巨大症のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・先端巨大症の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・先端巨大症の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Acromegaly market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Acromegaly size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Acromegaly market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Acromegaly market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
Market segment by Application, can be divided into
Hospitals
Clinics
Market segment by players, this report covers
Novartis
Aegis Therapeutics
Chiasma
Crinetics Pharmaceuticals
Daewoong Pharmaceutical
Peptron
Silence Therapeutics
Strongbridge Biopharma
Amryt Pharma
Foresee Pharmaceuticals
Glide Pharmaceutical
Ionis Pharmaceuticals
Ipsen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Acromegaly
1.2 Classification of Acromegaly by Type
1.2.1 Overview: Global Acromegaly Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Acromegaly Revenue Market Share by Type in 2020
1.2.3 Somatostatin Analogues
1.2.4 Dopamine Agonists
1.2.5 Growth Hormone Receptor Antagonists
1.2.6 Other
1.3 Global Acromegaly Market by Application
1.3.1 Overview: Global Acromegaly Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Acromegaly Market Size & Forecast
1.5 Global Acromegaly Market Size and Forecast by Region
1.5.1 Global Acromegaly Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Acromegaly Market Size by Region, (2016-2021)
1.5.3 North America Acromegaly Market Size and Prospect (2016-2026)
1.5.4 Europe Acromegaly Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Acromegaly Market Size and Prospect (2016-2026)
1.5.6 South America Acromegaly Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Acromegaly Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Acromegaly Market Drivers
1.6.2 Acromegaly Market Restraints
1.6.3 Acromegaly Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Acromegaly Product and Solutions
2.1.4 Novartis Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Aegis Therapeutics
2.2.1 Aegis Therapeutics Details
2.2.2 Aegis Therapeutics Major Business
2.2.3 Aegis Therapeutics Acromegaly Product and Solutions
2.2.4 Aegis Therapeutics Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Aegis Therapeutics Recent Developments and Future Plans
2.3 Chiasma
2.3.1 Chiasma Details
2.3.2 Chiasma Major Business
2.3.3 Chiasma Acromegaly Product and Solutions
2.3.4 Chiasma Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Chiasma Recent Developments and Future Plans
2.4 Crinetics Pharmaceuticals
2.4.1 Crinetics Pharmaceuticals Details
2.4.2 Crinetics Pharmaceuticals Major Business
2.4.3 Crinetics Pharmaceuticals Acromegaly Product and Solutions
2.4.4 Crinetics Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Crinetics Pharmaceuticals Recent Developments and Future Plans
2.5 Daewoong Pharmaceutical
2.5.1 Daewoong Pharmaceutical Details
2.5.2 Daewoong Pharmaceutical Major Business
2.5.3 Daewoong Pharmaceutical Acromegaly Product and Solutions
2.5.4 Daewoong Pharmaceutical Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Daewoong Pharmaceutical Recent Developments and Future Plans
2.6 Peptron
2.6.1 Peptron Details
2.6.2 Peptron Major Business
2.6.3 Peptron Acromegaly Product and Solutions
2.6.4 Peptron Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Peptron Recent Developments and Future Plans
2.7 Silence Therapeutics
2.7.1 Silence Therapeutics Details
2.7.2 Silence Therapeutics Major Business
2.7.3 Silence Therapeutics Acromegaly Product and Solutions
2.7.4 Silence Therapeutics Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Silence Therapeutics Recent Developments and Future Plans
2.8 Strongbridge Biopharma
2.8.1 Strongbridge Biopharma Details
2.8.2 Strongbridge Biopharma Major Business
2.8.3 Strongbridge Biopharma Acromegaly Product and Solutions
2.8.4 Strongbridge Biopharma Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Strongbridge Biopharma Recent Developments and Future Plans
2.9 Amryt Pharma
2.9.1 Amryt Pharma Details
2.9.2 Amryt Pharma Major Business
2.9.3 Amryt Pharma Acromegaly Product and Solutions
2.9.4 Amryt Pharma Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Amryt Pharma Recent Developments and Future Plans
2.10 Foresee Pharmaceuticals
2.10.1 Foresee Pharmaceuticals Details
2.10.2 Foresee Pharmaceuticals Major Business
2.10.3 Foresee Pharmaceuticals Acromegaly Product and Solutions
2.10.4 Foresee Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Foresee Pharmaceuticals Recent Developments and Future Plans
2.11 Glide Pharmaceutical
2.11.1 Glide Pharmaceutical Details
2.11.2 Glide Pharmaceutical Major Business
2.11.3 Glide Pharmaceutical Acromegaly Product and Solutions
2.11.4 Glide Pharmaceutical Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Glide Pharmaceutical Recent Developments and Future Plans
2.12 Ionis Pharmaceuticals
2.12.1 Ionis Pharmaceuticals Details
2.12.2 Ionis Pharmaceuticals Major Business
2.12.3 Ionis Pharmaceuticals Acromegaly Product and Solutions
2.12.4 Ionis Pharmaceuticals Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Ionis Pharmaceuticals Recent Developments and Future Plans
2.13 Ipsen
2.13.1 Ipsen Details
2.13.2 Ipsen Major Business
2.13.3 Ipsen Acromegaly Product and Solutions
2.13.4 Ipsen Acromegaly Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Ipsen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Acromegaly Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Acromegaly Players Market Share
3.2.2 Top 10 Acromegaly Players Market Share
3.2.3 Market Competition Trend
3.3 Acromegaly Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Acromegaly Revenue and Market Share by Type (2016-2021)
4.2 Global Acromegaly Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Acromegaly Revenue Market Share by Application (2016-2021)
5.2 Acromegaly Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Acromegaly Revenue by Type (2016-2026)
6.2 North America Acromegaly Revenue by Application (2016-2026)
6.3 North America Acromegaly Market Size by Country
6.3.1 North America Acromegaly Revenue by Country (2016-2026)
6.3.2 United States Acromegaly Market Size and Forecast (2016-2026)
6.3.3 Canada Acromegaly Market Size and Forecast (2016-2026)
6.3.4 Mexico Acromegaly Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Acromegaly Revenue by Type (2016-2026)
7.2 Europe Acromegaly Revenue by Application (2016-2026)
7.3 Europe Acromegaly Market Size by Country
7.3.1 Europe Acromegaly Revenue by Country (2016-2026)
7.3.2 Germany Acromegaly Market Size and Forecast (2016-2026)
7.3.3 France Acromegaly Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Acromegaly Market Size and Forecast (2016-2026)
7.3.5 Russia Acromegaly Market Size and Forecast (2016-2026)
7.3.6 Italy Acromegaly Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Acromegaly Revenue by Type (2016-2026)
8.2 Asia-Pacific Acromegaly Revenue by Application (2016-2026)
8.3 Asia-Pacific Acromegaly Market Size by Region
8.3.1 Asia-Pacific Acromegaly Revenue by Region (2016-2026)
8.3.2 China Acromegaly Market Size and Forecast (2016-2026)
8.3.3 Japan Acromegaly Market Size and Forecast (2016-2026)
8.3.4 South Korea Acromegaly Market Size and Forecast (2016-2026)
8.3.5 India Acromegaly Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Acromegaly Market Size and Forecast (2016-2026)
8.3.7 Australia Acromegaly Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Acromegaly Revenue by Type (2016-2026)
9.2 South America Acromegaly Revenue by Application (2016-2026)
9.3 South America Acromegaly Market Size by Country
9.3.1 South America Acromegaly Revenue by Country (2016-2026)
9.3.2 Brazil Acromegaly Market Size and Forecast (2016-2026)
9.3.3 Argentina Acromegaly Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Acromegaly Revenue by Type (2016-2026)
10.2 Middle East & Africa Acromegaly Revenue by Application (2016-2026)
10.3 Middle East & Africa Acromegaly Market Size by Country
10.3.1 Middle East & Africa Acromegaly Revenue by Country (2016-2026)
10.3.2 Turkey Acromegaly Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Acromegaly Market Size and Forecast (2016-2026)
10.3.4 UAE Acromegaly Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Acromegaly Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Acromegaly Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Acromegaly Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Acromegaly Revenue (USD Million) by Region (2016-2021)
Table 5. Global Acromegaly Revenue Market Share by Region (2021-2026)
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis Acromegaly Product and Solutions
Table 9. Novartis Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Aegis Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Aegis Therapeutics Major Business
Table 12. Aegis Therapeutics Acromegaly Product and Solutions
Table 13. Aegis Therapeutics Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Chiasma Corporate Information, Head Office, and Major Competitors
Table 15. Chiasma Major Business
Table 16. Chiasma Acromegaly Product and Solutions
Table 17. Chiasma Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Crinetics Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Crinetics Pharmaceuticals Major Business
Table 20. Crinetics Pharmaceuticals Acromegaly Product and Solutions
Table 21. Crinetics Pharmaceuticals Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Daewoong Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 23. Daewoong Pharmaceutical Major Business
Table 24. Daewoong Pharmaceutical Acromegaly Product and Solutions
Table 25. Daewoong Pharmaceutical Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Peptron Corporate Information, Head Office, and Major Competitors
Table 27. Peptron Major Business
Table 28. Peptron Acromegaly Product and Solutions
Table 29. Peptron Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Silence Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Silence Therapeutics Major Business
Table 32. Silence Therapeutics Acromegaly Product and Solutions
Table 33. Silence Therapeutics Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Strongbridge Biopharma Corporate Information, Head Office, and Major Competitors
Table 35. Strongbridge Biopharma Major Business
Table 36. Strongbridge Biopharma Acromegaly Product and Solutions
Table 37. Strongbridge Biopharma Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Amryt Pharma Corporate Information, Head Office, and Major Competitors
Table 39. Amryt Pharma Major Business
Table 40. Amryt Pharma Acromegaly Product and Solutions
Table 41. Amryt Pharma Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Foresee Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. Foresee Pharmaceuticals Major Business
Table 44. Foresee Pharmaceuticals Acromegaly Product and Solutions
Table 45. Foresee Pharmaceuticals Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Glide Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 47. Glide Pharmaceutical Major Business
Table 48. Glide Pharmaceutical Acromegaly Product and Solutions
Table 49. Glide Pharmaceutical Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Ionis Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 51. Ionis Pharmaceuticals Major Business
Table 52. Ionis Pharmaceuticals Acromegaly Product and Solutions
Table 53. Ionis Pharmaceuticals Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Ipsen Corporate Information, Head Office, and Major Competitors
Table 55. Ipsen Major Business
Table 56. Ipsen Acromegaly Product and Solutions
Table 57. Ipsen Acromegaly Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Acromegaly Revenue (USD Million) by Players (2019-2021)
Table 59. Global Acromegaly Revenue Share by Players (2019-2021)
Table 60. Breakdown of Acromegaly by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Acromegaly Players Head Office, Products and Services Provided
Table 62. Acromegaly Mergers & Acquisitions in the Past Five Years
Table 63. Acromegaly New Entrants and Expansion Plans
Table 64. Global Acromegaly Revenue (USD Million) by Type (2016-2021)
Table 65. Global Acromegaly Revenue Share by Type (2016-2021)
Table 66. Global Acromegaly Revenue Forecast by Type (2021-2026)
Table 67. Global Acromegaly Revenue by Application (2016-2021)
Table 68. Global Acromegaly Revenue Forecast by Application (2021-2026)
Table 69. North America Acromegaly Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Acromegaly Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Acromegaly Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Acromegaly Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Acromegaly Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Acromegaly Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Acromegaly Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Acromegaly Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Acromegaly Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Acromegaly Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Acromegaly Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Acromegaly Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Acromegaly Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Acromegaly Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Acromegaly Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Acromegaly Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Acromegaly Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Acromegaly Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Acromegaly Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Acromegaly Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Acromegaly Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Acromegaly Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Acromegaly Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Acromegaly Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Acromegaly Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Acromegaly Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Acromegaly Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Acromegaly Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Acromegaly Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Acromegaly Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Acromegaly Picture
Figure 2. Global Acromegaly Revenue Market Share by Type in 2020
Figure 3. Somatostatin Analogues
Figure 4. Dopamine Agonists
Figure 5. Growth Hormone Receptor Antagonists
Figure 6. Other
Figure 7. Acromegaly Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Global Acromegaly Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Acromegaly Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Acromegaly Revenue Market Share by Region (2016-2026)
Figure 13. Global Acromegaly Revenue Market Share by Region in 2020
Figure 14. North America Acromegaly Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Acromegaly Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Acromegaly Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Acromegaly Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Acromegaly Market Drivers
Figure 19. Acromegaly Market Restraints
Figure 20. Acromegaly Market Trends
Figure 21. Novartis Recent Developments and Future Plans
Figure 22. Aegis Therapeutics Recent Developments and Future Plans
Figure 23. Chiasma Recent Developments and Future Plans
Figure 24. Crinetics Pharmaceuticals Recent Developments and Future Plans
Figure 25. Daewoong Pharmaceutical Recent Developments and Future Plans
Figure 26. Peptron Recent Developments and Future Plans
Figure 27. Silence Therapeutics Recent Developments and Future Plans
Figure 28. Strongbridge Biopharma Recent Developments and Future Plans
Figure 29. Amryt Pharma Recent Developments and Future Plans
Figure 30. Foresee Pharmaceuticals Recent Developments and Future Plans
Figure 31. Glide Pharmaceutical Recent Developments and Future Plans
Figure 32. Ionis Pharmaceuticals Recent Developments and Future Plans
Figure 33. Ipsen Recent Developments and Future Plans
Figure 35. Global Acromegaly Revenue Share by Players in 2020
Figure 36. Acromegaly Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Acromegaly Revenue Market Share in 2020
Figure 38. Global Top 10 Players Acromegaly Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Acromegaly Revenue Share by Type in 2020
Figure 41. Global Acromegaly Market Share Forecast by Type (2021-2026)
Figure 42. Global Acromegaly Revenue Share by Application in 2020
Figure 43. Global Acromegaly Market Share Forecast by Application (2021-2026)
Figure 44. North America Acromegaly Sales Market Share by Type (2016-2026)
Figure 45. North America Acromegaly Sales Market Share by Application (2016-2026)
Figure 46. North America Acromegaly Revenue Market Share by Country (2016-2026)
Figure 47. United States Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Acromegaly Sales Market Share by Type (2016-2026)
Figure 51. Europe Acromegaly Sales Market Share by Application (2016-2026)
Figure 52. Europe Acromegaly Revenue Market Share by Country (2016-2026)
Figure 53. Germany Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Acromegaly Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Acromegaly Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Acromegaly Revenue Market Share by Region (2016-2026)
Figure 61. China Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Acromegaly Sales Market Share by Type (2016-2026)
Figure 68. South America Acromegaly Sales Market Share by Application (2016-2026)
Figure 69. South America Acromegaly Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Acromegaly Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Acromegaly Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Acromegaly Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Acromegaly Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の先端巨大症市場規模・現状・予測（2021年-2027年） Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults. Market Analysis and Insights: Globa…- 世界の先端巨大症治療市場規模・現状・予測（2021年-2027年） Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly. Market Analysis and Insights: Global Acromegaly Therapeutics Market The global Acromegaly Therapeutics market size is projected to reach US$ X…
- 世界のクッシング症候群・先端巨大症治療市場規模・現状・予測（2021年-2027年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly …
- 世界の先端巨大症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acromegaly Treatment Market The global Acromegaly Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の先端巨大症治療市場 2021：企業別、地域別、種類・用途別 The Acromegaly Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…